PATENT CLAIM ANALYSIS

Application Number: 16046893
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "449000"]

Abstract:
Provided herein are substituted biaryl sulfonamide compounds, pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or amelioration of various disorders, including cancer and proliferative disorders. In one embodiment, the compounds provided herein modulate initiation of protein translation. In one embodiment, the compounds provided herein are used in combination with surgery, radiation therapy, immuno therapy and/or one or more additional anticancer drugs for the treatment, prevention, and/or amelioration of cancer and proliferative disorders.

Claim (Index 39):
The method of any one of  claims 34  or  35 , wherein the cancer is cytarabine-resistant.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 95.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14092425', '14871472', '15434531', '14871552', '14250089']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8361549225117362
- 35 USC 102 Novelty (BERT): 0.5513834066762345
- Combined Prediction Score: 0.807677770928186
- Mean Citation Score: 416.27998400000007
- Max Citation Score: 453.67273
- Similarity Product: 281.54296189411764

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test